APP and Alzheimer disease: Studies have shown evidence about involvement of TLR-4 in AD disease that the postmortem brain of AD patients exhibited high levels of TLR-4 expression, and once amyloid precursor protein (APP) is overexpressed in mouse brains, the upregulation of TLR-4 expression was detected [31].